Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The US Institute for Advanced Sinus Care and Research is a specialized medical facility and clinical research center focused on the diagnosis and treatment of complex sinus and nasal disorders. Led by Dr. Boris Karanfilov, the institute provides advanced surgical and non-surgical interventions, including balloon sinuplasty and biologic therapies. In addition to patient care, the organization serves as a high-volume clinical trial site, participating in multi-center studies for novel pharmaceuticals and medical devices. Their research focus primarily targets chronic rhinosinusitis, nasal polyposis, and respiratory allergies. The institute is recognized for its expertise in evaluating monoclonal antibodies and innovative drug delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on US Institute for Advanced Sinus Care and Research.